HR+/HER2- Breast cancer epidemiology: How the prevalence is changing the population trends?



HR-positive/HER2-negative breast cancer is the most prevalent form of breast cancer disease. This type reports having a higher percentage among all breast cancers. 
HR positive/ HER2 negative breast cancer market
Hormone receptors (HR) are the proteins, which receive hormone signals and command the cancer cells to proliferate. If the breast cancer cells receive signals from the hormone estrogen that could promote tumour growth, then it is called as estrogen receptor-positive (ER+) breast cancer. If cancerous cells receive the signals from the hormone progesterone that could spur the growth, it is called progesterone receptor-positive (PR+) breast cancer. Also, human epidermal growth factor receptor 2 (HER2) is a gene that aids in controlling how cells grow, divide, and repair themselves.

 
Many women have breast cancer globally; the prevalence is increasing every day. DelveInsight has reported that the total Breast Cancer incident population in the 7MM is expected to grow at CAGR of 0.83%, during the study period [2017–2028] in their epidemiology model for HR-positive/ HER2-negative Breast Cancer market report.
HR positive/ HER2 negative breast cancer market epidemiology
It was also reported that the United States show a higher incidence of Breast Cancer in the United States with 266,120 cases in 2017. Among the EU-5 countries, Germany ranked first with 71,585 cases in 2017, followed by Italy, and France, in 2017. On the other hand, Spain has the least number of breast cancer incident cases which was equivalent to 11.99% of the total EU-5 breast cancer cases.  

 
While taking into account of Japan, it accounts for the second-highest breast cancer incident cases among the 7MM countries. In 2017, it was observed that the incident population of breast cancer in Japan was found to be 89,100, which was equivalent to 14.21% of the total breast cancer incident population.

In all other 7MM countries, excluding Japan, among the various subtypes of the disease, HR-positive/HER2-negative occupies the maximum patient pool, followed by the number of those with Triple-negative and HR-positive/HER2-positive. On the other hand, HR-negative/HER2-positive accommodated the least number of cases. Furthermore, from the category of HR-positive/HER2-negative, ER+ is primarily responsible for HR-positive cases.

DelveInsight’s HR-positive/HER2-negative breast cancer market research report has included Epidemiology Segmentation (7MM for 2017–2028) as Total Incident cases of Breast Cancer in the 7MM, Breast Cancer Incidence Cases by Menopausal Status, Stage Specific Incidence of Breast Cancer in Post-Menopausal Women, Stage Specific Diagnosed Incidence of Breast Cancer in Post- Menopausal Women, Diagnosed Incidence of Early Stage Breast Cancer in Postmenopause by Molecular Subtype, Diagnosed Incidence of Locally Advanced and Metastatic Breast Cancer in Postmenopause by Molecular Subtypes. The market report proffers the exhaustive epidemiological trends and epidemiology forecast covering the seven major markets. 


Comments

  1. UnknownFebruary 27, 2020 at 7:05 AM

    Did you hear there is a 12 word phrase you can communicate to your crush... that will trigger deep emotions of love and impulsive appeal to you buried within his chest?

    Because hidden in these 12 words is a "secret signal" that fuels a man's impulse to love, admire and guard you with all his heart...

    12 Words Will Fuel A Man's Desire Response

    This impulse is so hardwired into a man's mind that it will drive him to work better than before to make your relationship as strong as it can be.

    Matter-of-fact, fueling this mighty impulse is absolutely essential to getting the best possible relationship with your man that the second you send your man a "Secret Signal"...

    ...You will immediately find him open his heart and mind for you in such a way he's never experienced before and he will see you as the one and only woman in the world who has ever truly interested him.

    ReplyDelete

Post a Comment

Popular posts from this blog

Tenosynovial Giant Cell Tumors (TSGCTs) Market Research Report 2030 | Tenosynovial Giant Cell Tumors (TSGCTs) Market

Image
Tenosynovial Giant Cell Tumors   are a type of neoplasm that affects synovial-lined tendon sheaths, synovial joints, and surrounding soft tissue. Locally aggressive benign tissue lesions are defined by synovial lining inflammation in joints and tendons. Overexpression of the colony-stimulating factor 1 receptor is thought to cause these tumors to form. Giant cell tumors of the tendon sheath (GCTTS), pigmented villonodular tumors (PVNTS), extra-articular pigmented villonodular tumors of the tendon sheath, and localized or focal nodular synovitis are all terms used to describe TSGCTs. Tenosynovial Giant Cell Tumors Causes Translocation is an alteration to a chromosome that causes Tenosynovial Giant Cell Tumors. A chromosome segment breaks off and moves around. The cause of these translocations is unknown. The genetic code for making proteins is stored on chromosomes. A protein termed colony-stimulating factor 1 is produced in excess due to the translocation (CSF1). This protein attracts
Read more

Functional Dyspepsia Market Research Report 2030 | Functional Dyspepsia Market

Image
  Functional dyspepsia   is a term for recurring signs and symptoms of indigestion that have no apparent cause. Functional dyspepsia is also called non-ulcer stomach pain or non-ulcer dyspepsia. It's not clear what causes functional dyspepsia. Doctors consider it a functional disorder, which means that routine testing may not show any abnormalities. Hence, it is diagnosed based on symptoms. Functional Dyspepsia Signs and Symptoms  Functional dyspepsia is common and can be long-lasting — although signs and symptoms are mostly intermittent. These signs and symptoms resemble those of an ulcer, discomfort in your upper abdomen, often accompanied by bloating, belching, and nausea, An early feeling of fullness (satiety) when eating, Pain in the stomach that may sometimes occur unrelated to meals, or maybe relieved with meals. Functional Dyspepsia Epidemiology According to an article by Madisch et al. (2018), Functional Dyspepsia is one of the common functional disorders, with a prevalenc
Read more

Fibrodysplasia Ossificans Progressiva Market Research Report 2030 | Fibrodysplasia Ossificans Progressiva Market

Image
  Fibrodysplasia ossificans progressiva   is a disorder in which the skeleton, muscles, and connective tissues, such as tendons and ligaments, are replaced by bone (ossified). This position was to lead to the formation of the bones of the skeleton (extra-skeletal or heterotopic bone) that constrains movement. Fibrodysplasia ossificans progressiva Causes Fibrodysplasia ossificans progressiva is called a mutation in the ACVR1 gene. This gene is involved in bone growth and development. Mutations, and the possibility of a disorderly development. The gene can be inherited from a parent, but in most cases, the, is a new mutation, a person with a less-than-a family history of the disease. As a parent, they have a 50% chance of passing it on to their children. Fibrodysplasia ossificans progressiva Sign and Symptoms The  Fibrodysplasia ossificans progressiva  symptoms begin in the first decade of life with episodes of painful inflammatory soft tissue swellings. Gradually, there occurs restricti
Read more